dose for aod9604 AOD-9604 + CJC-1295 + Ipamorelin (12mg Blend Vial) Dosage Protocol AOD 9604 Dosage Guide: Uses,

The reduction in visceral fat was sustained over the study period, but the fat tended to return to baseline levels upon discontinuation of the therapy, indicating the need for ongoing treatment to maintain these benefits

8-12 weeks

The larger, longer trial failed to show significant results at all

S2) UniFrac analyses and BrayCurtis dissimilarity analysis (Supplementary Fig

Adherent cells were scrapped, then centrifuged at 4 C

Reviewed by Brandon Johnson Certified Personal Trainer, Nutrition Coach & Peptide Research Consultant Brandon Johnson is a certified personal trainer, nutrition coach, and peptide research consultant with a background in kinesiology and over 15 years of experience in fitness and wellness